292 related articles for article (PubMed ID: 15606152)
21. Electrochemical and conformational consequences of copper (Cu(I) and Cu(II)) binding to beta-amyloid(1-40).
Brzyska M; Trzesniewska K; Wieckowska A; Szczepankiewicz A; Elbaum D
Chembiochem; 2009 Apr; 10(6):1045-55. PubMed ID: 19263448
[TBL] [Abstract][Full Text] [Related]
22. Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity.
Boyd-Kimball D; Sultana R; Mohmmad-Abdul H; Butterfield DA
J Alzheimers Dis; 2004 Oct; 6(5):515-25. PubMed ID: 15505374
[TBL] [Abstract][Full Text] [Related]
23. Mutation of the Phe20 residue in Alzheimer's amyloid beta-peptide might decrease its toxicity due to disruption of the Met35-cupric site electron transfer pathway.
Pogocki D
Chem Res Toxicol; 2004 Mar; 17(3):325-9. PubMed ID: 15025502
[TBL] [Abstract][Full Text] [Related]
24. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons.
Shelat PB; Chalimoniuk M; Wang JH; Strosznajder JB; Lee JC; Sun AY; Simonyi A; Sun GY
J Neurochem; 2008 Jul; 106(1):45-55. PubMed ID: 18346200
[TBL] [Abstract][Full Text] [Related]
25. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
Sultana R; Perluigi M; Butterfield DA
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
[TBL] [Abstract][Full Text] [Related]
26. Catecholamines potentiate amyloid beta-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis.
Fu W; Luo H; Parthasarathy S; Mattson MP
Neurobiol Dis; 1998 Oct; 5(4):229-43. PubMed ID: 9848093
[TBL] [Abstract][Full Text] [Related]
27. Methionine 35 oxidation reduces toxic effects of the amyloid beta-protein fragment (31-35) on human red blood cell.
Clementi ME; Martorana GE; Pezzotti M; Giardina B; Misiti F
Int J Biochem Cell Biol; 2004 Oct; 36(10):2066-76. PubMed ID: 15203119
[TBL] [Abstract][Full Text] [Related]
28. Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity.
Giuffrida ML; Grasso G; Ruvo M; Pedone C; Saporito A; Marasco D; Pignataro B; Cascio C; Copani A; Rizzarelli E
J Neurosci Res; 2007 Feb; 85(3):623-33. PubMed ID: 17131391
[TBL] [Abstract][Full Text] [Related]
29. Amyloid beta-peptide(1-42) and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures.
Fonfria E; Marshall IC; Boyfield I; Skaper SD; Hughes JP; Owen DE; Zhang W; Miller BA; Benham CD; McNulty S
J Neurochem; 2005 Nov; 95(3):715-23. PubMed ID: 16104849
[TBL] [Abstract][Full Text] [Related]
30. Copper catalyzed oxidation of Alzheimer Abeta.
Atwood CS; Huang X; Khatri A; Scarpa RC; Kim YS; Moir RD; Tanzi RE; Roher AE; Bush AI
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):777-83. PubMed ID: 10875439
[TBL] [Abstract][Full Text] [Related]
31. Role of peroxynitrite in the vasoactive and cytotoxic effects of Alzheimer's beta-amyloid1-40 peptide.
Paris D; Parker TA; Town T; Suo Z; Fang C; Humphrey J; Crawford F; Mullan M
Exp Neurol; 1998 Jul; 152(1):116-22. PubMed ID: 9682018
[TBL] [Abstract][Full Text] [Related]
32. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
Song MS; Rauw G; Baker GB; Kar S
Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
[TBL] [Abstract][Full Text] [Related]
33. Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment.
Hernández-Guillamon M; Delgado P; Ortega L; Pares M; Rosell A; García-Bonilla L; Fernández-Cadenas I; Borrell-Pagès M; Boada M; Montaner J
J Neurosci Res; 2009 Jul; 87(9):2115-25. PubMed ID: 19235898
[TBL] [Abstract][Full Text] [Related]
34. Surface structure of amyloid-beta fibrils contributes to cytotoxicity.
Yoshiike Y; Akagi T; Takashima A
Biochemistry; 2007 Aug; 46(34):9805-12. PubMed ID: 17676931
[TBL] [Abstract][Full Text] [Related]
35. Modulation of calcium/calmodulin kinase-II provides partial neuroprotection against beta-amyloid peptide toxicity.
Lin KF; Chang RC; Suen KC; So KF; Hugon J
Eur J Neurosci; 2004 Apr; 19(8):2047-55. PubMed ID: 15090032
[TBL] [Abstract][Full Text] [Related]
36. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.
Cardoso SM; Santana I; Swerdlow RH; Oliveira CR
J Neurochem; 2004 Jun; 89(6):1417-26. PubMed ID: 15189344
[TBL] [Abstract][Full Text] [Related]
37. Why is the amyloid beta peptide of Alzheimer's disease neurotoxic?
Rauk A
Dalton Trans; 2008 Mar; (10):1273-82. PubMed ID: 18305836
[TBL] [Abstract][Full Text] [Related]
38. Aluminum modulates effects of beta amyloid(1-42) on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease.
Drago D; Cavaliere A; Mascetra N; Ciavardelli D; di Ilio C; Zatta P; Sensi SL
Rejuvenation Res; 2008 Oct; 11(5):861-71. PubMed ID: 18788899
[TBL] [Abstract][Full Text] [Related]
39. The Cu(II)/Abeta/human serum albumin model of control mechanism for copper-related amyloid neurotoxicity.
Rózga M; Bal W
Chem Res Toxicol; 2010 Feb; 23(2):298-308. PubMed ID: 19950960
[TBL] [Abstract][Full Text] [Related]
40. The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42.
Finder VH; Vodopivec I; Nitsch RM; Glockshuber R
J Mol Biol; 2010 Feb; 396(1):9-18. PubMed ID: 20026079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
